Pretreatment of 4T1 breast cancer cells with TGFβ increased their susceptibility to neutrophil-mediated cytotoxicity [68], which might be explained by the more apoptosis-prone mesenchymal phenotype of TGFβ-treated tumor cells [276]. Here, TGFB1 is linked to breast cancer.